|
|
|
The COVID-19 Impact in New Orleans and on GU Cancer Care
|
|
A. Oliver Sartor, MD
|
| Oliver Sartor joins Alicia Morgans sharing an update on his perspective of the novel Coronavirus 2019 (COVID-19), and the current disruption in healthcare in New Orleans, Louisiana.
|
|
|
|
|
|
|
|
|
|
|
|
|
The COVID-19 and Cancer Consortium: Understanding the Effects of COVID-19 on Patients with GU Cancers
|
|
Petros Grivas, MD, Ph.D.
|
| Petros Grivas joins Alicia Morgans to describe the work of the COVID-19 and Cancer Consortium, a group of 100 institutions spanning the United States, Canada and Spain which has aimed to use "crowdsourcing" to collect data on how COVID-19 is impacting cancer patients.
|
|
|
|
|
|
|
|
|
|
|
|
|
Bladder Cancer in Times of COVID-19 in India
|
|
Pradeep P. Rao, MB, DNB (Urol), FRCSEd, FRCS (Glas)
|
| Pradeep Rao joins UroToday to discuss the state of bladder cancer treatment and diagnosis in India. Dr. Rao describes issues regarding the lack of a bladder cancer registry and a variation in the quality of TURBT across India, as well as the problem arising from limited access to blue light for screening.
|
|
|
|
|
|
|
|
|
|
|
|
|
NCCN Metastatic Castration-Resistant Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic
|
|
Alicia Morgans, MD, MPH
|
| The National Comprehensive Cancer Network (NCCN) released new guidelines on April 1, 2020, directing cancer care during the COVID-19 crisis Alicia Morgans and Edward Schaeffer address patient questions about their primary treatment concerns during this unprecedented time.
|
|
|
|
|
|
|
|
|
|
| NCCN Localized Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic
|
| Edward M. Schaeffer, MD, Ph.D.
|
| Edward (Ted) Schaeffer provides the urologist's perspective while answering patient questions on treatment considerations for localized prostate cancer in light of the COVID-19 crisis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EDITOR SELECTED ABSTRACTS AND COMMENTARIES |
|
|
|
|
|
|
|
Biomarker Strategies for Prostate Cancer Care During COVID-19
|
|
Neal Shore, MD, FACS
|
| Despite the recent disruptions in health care delivery due to the COVID-19 pandemic, patients at risk for developing prostate cancer as well as those diagnosed with prostate cancer still deserve timely and optimal decision making. Unfortunately, the uncertainty of the pandemic requires urologists to adopt innovative strategies in order to prioritize patient care while being mindful to mitigate the potential infectious risks of COVID-19 to their patients as well as to their healthcare team.
|
|
|
|
|
|
|
|
|
| State-of-the-Art Lecture: Has Electronic Medical Records (EMR) Improved Patient Care?
|
| Peter Basch, MD
|
| In a plenary session at the American Urologic Association 2020 Virtual Annual Meeting this after, Peter Basch presented a state of the art lecture addressing the question of whether electronic medical records (EMR) have improved patient care.
|
|
|
|
|
|
| Coronavirus Infections: More Than Just the Common Cold
|
| Anthony Fauci, MD
|
| At the 2020 American Urologic Association Virtual Annual Meeting, Anthony Fauci gave a presentation on the current worldwide pandemic caused by COVID-19.
|
|
|
|
|
|
|
